Publications
Detailed Information
A Comparison of Pioglitazone vs Rosiglitazone for Heart Failure in Elderly Type 2 Patients
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Seong, Jong-Mi | - |
| dc.contributor.author | Choi, Nam-Kyong | - |
| dc.contributor.author | Jung, Sun-Young | - |
| dc.contributor.author | Kim, Ye-Jee | - |
| dc.contributor.author | Phark, Byung-Joo | - |
| dc.contributor.author | Lee, Joongyub | - |
| dc.date.accessioned | 2012-06-27T00:48:03Z | - |
| dc.date.available | 2012-06-27T00:48:03Z | - |
| dc.date.issued | 2009-08 | - |
| dc.identifier.citation | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY; Vol.18 ; S153-S153 | ko_KR |
| dc.identifier.issn | 1053-8569 | - |
| dc.identifier.uri | https://hdl.handle.net/10371/77505 | - |
| dc.description.abstract | Background: Recent studies have raised concerns about
risk of heart failure (HF) in type 2 diabetic patients treated with thiazolidinedions (TZDs), but there were little data comparing the risk of HF within TZDs. | ko_KR |
| dc.language.iso | en | ko_KR |
| dc.publisher | JOHN WILEY & SONS LTD | ko_KR |
| dc.title | A Comparison of Pioglitazone vs Rosiglitazone for Heart Failure in Elderly Type 2 Patients | ko_KR |
| dc.type | Article | ko_KR |
| dc.contributor.AlternativeAuthor | 성종미 | - |
| dc.contributor.AlternativeAuthor | 최남경 | - |
| dc.contributor.AlternativeAuthor | 정선영 | - |
| dc.contributor.AlternativeAuthor | 김예지 | - |
| dc.contributor.AlternativeAuthor | 이중엽 | - |
| dc.contributor.AlternativeAuthor | 박병주 | - |
| dc.citation.journaltitle | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - |
| dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.